The strength of the current study is the adjustment for well-established diabetes risk factors (including liver enzymes), and using comprehensive statistical methods (AUC, NRI and IDI) to explore the predictive utility of FGF-21. This evidence concerns the gene FGF21 and diabetes mellitus.